“It came as a surprise that our approach works so well,” Lu said. In preclinical (non-human) studies, the vaccine completely ...

Scientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...

A vaccine for pancreatic cancer is showing promise. Here's how it works. 05:25 When a routine scan led to Barbara Brigham's pancreatic cancer diagnosis in 2020, all she could think about was how ...

Pancreatic cancer vaccine eradicates trace of disease in early trials. Treatment hope: Vaccine has the potential to kill all pancreatic cancer cells. Depositphotos. View 1 Image 1 / 1.

Personalized mRNA vaccines show promise as pancreatic cancer treatment, a phase 1 clinical trial published Wednesday in Nature found. Fewer than 13% of people diagnosed with pancreatic cancer live ...

Nanoparticle-based vaccines targeting common pancreatic cancer mutations induced strong anti-tumor immune responses in preclinical models of pancreatic ductal adenocarcinoma (PDAC), with over half ...

Pancreatic cancer is notoriously difficult to treat, and about 90% of diagnosed patients die from the disease. A team at Memorial Sloan Kettering has been working to improve those outcomes by ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.

The American Cancer Society estimates that about 67,440 Americans (34,950 men and 32,490 women) will be diagnosed with pancreatic cancer this year. Of those, about 51,980 people (27,050 men and ...

An expert discussed ELI-002 7P, the investigational pancreatic cancer vaccine. He explained how it works and what patients can expect regarding the ongoing research. ELI-002 7P is a vaccine being ...